MicroRNA-106b-25 cluster expression is associated with early disease recurrence and targets caspase-7 and focal adhesion in human prostate cancer
Open Access
- 17 September 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 32 (35), 4139-4147
- https://doi.org/10.1038/onc.2012.424
Abstract
The miR-106b-25 microRNA (miRNA) cluster is a candidate oncogene in human prostate cancer. Here, we report that miRNAs encoded by miR-106b-25 are upregulated in both primary tumors and distant metastasis. Moreover, increased tumor miR-106b expression was associated with disease recurrence and the combination of high miR-106b and low CASP7 (caspase-7) expressions in primary tumors was an independent predictor of early disease recurrence (adjusted hazard ratio=4.1; 95% confidence interval: 1.6–12.3). To identify yet unknown oncogenic functions of miR-106b, we overexpressed it in LNCaP human prostate cancer cells to examine miR-106b-induced global expression changes among protein-coding genes. The approach revealed that CASP7 is a direct target of miR-106b, which was confirmed by western blot analysis and a 3′-untranslated region reporter assay. Moreover, selected phenotypes induced by miR-106b knockdown in DU145 human prostate cancer cells did not develop when both miR-106b and CASP7 expression were inhibited. Further analyses showed that CASP7 is downregulated in primary prostate tumors and metastatic lesions across multiple data sets and is by itself associated with disease recurrence and disease-specific survival. Using bioinformatics, we also observed that miR-106b-25 may specifically influence focal adhesion-related pathways. This observation was experimentally examined using miR-106b-25-transduced 22Rv1 human prostate cancer cells. After infection with a miR-106b-25 lentiviral expression construct, 22Rv1 cells showed increased adhesion to basement membrane- and bone matrix-related filaments and enhanced soft agar growth. In summary, miR-106b-25 was found to be associated with prostate cancer progression and disease outcome and may do so by altering apoptosis- and focal adhesion-related pathways.Keywords
This publication has 35 references indexed in Scilit:
- The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancerOncogene, 2012
- Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancerOncogene, 2012
- MicroRNA-32 Upregulation by 1,25-Dihydroxyvitamin D3 in Human Myeloid Leukemia Cells Leads to Bim Targeting and Inhibition of AraC-Induced ApoptosisCancer Research, 2011
- MicroRNA in Prostate, Bladder, and Kidney Cancer: A Systematic ReviewEuropean Urology, 2011
- Apoptosis and cancer: mutations within caspase genesJournal of Medical Genetics, 2009
- A microRNA polycistron as a potential human oncogeneNature, 2005
- RAS Is Regulated by the let-7 MicroRNA FamilyCell, 2005
- Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikisNature, 2003
- Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemiaProceedings of the National Academy of Sciences, 2002
- Prostate cancer in a transgenic mouse.Proceedings of the National Academy of Sciences of the United States of America, 1995